 |
|||||
|
|||||
|
|||||
|
|||||
|
|||||
The Journal of Neuroscience, February 13, 2008, 28(7):1640-1648; doi:10.1523/JNEUROSCI.3677-07.2008
Previous Article | Next Article
Neurobiology of Disease
Functional Characterization of Rab7 Mutant Proteins Associated with Charcot-Marie-Tooth Type 2B Disease
Maria Rita Spinosa, * Cinzia Progida, * Azzurra De Luca, Anna Maria Rosaria Colucci, Pietro Alifano, andCecilia Bucci Dipartimento di Scienze e Tecnologie Biologiche ed Ambientali, Università del Salento, 73100 Lecce, Italy
Correspondence should be addressed to Prof. Cecilia Bucci, Dipartimento di Scienze e Tecnologie Biologiche ed Ambientali, Università del Salento, Via Provinciale Monteroni, 73100 Lecce, Italy. Email: cecilia.bucci{at}unile.it
Charcot-Marie-Tooth (CMT) type 2 neuropathies are a group of autosomal-dominant axonal disorders genetically and clinically heterogeneous. In particular, CMT type 2B (CMT2B) neuropathies are characterized by severe sensory loss, often complicated by infections, arthropathy, and amputations. Recently, four missense mutations in the small GTPase Rab7 associated with the Charcot-Marie Tooth type 2B phenotype have been identified. These mutations target highly conserved amino acid residues. However, nothing is known about whether and how these mutations affect Rab7 function. We investigated the biochemical and functional properties of three of the mutant proteins. Interestingly, all three proteins exhibited higher nucleotide exchange rates and hydrolyzed GTP slower than the wild-type protein. In addition, whereas 23% of overexpressed wild-type Rab7 was GTP bound in HeLa cells, the large majority of the mutant proteins (82–89%) were in the GTP-bound form, consistent with the data on GTP hydrolysis and exchange rates. The CMT2B-associated Rab7 proteins were also able to bind the Rab7 effector RILP (Rab-interacting lysosomal protein) and to rescue Rab7 function after silencing. Altogether, these data demonstrate that all tested CMT2B-associated Rab7 mutations are mechanistically similar, suggesting that activated forms of the Rab7 are responsible for CMT2B disease.
Key words: Charcot-Marie-Tooth; neurodegeneration; axon degeneration; Rab7; endocytosis; Rab proteins
Received Aug. 13, 2007; revised Dec. 4, 2007; accepted Dec. 29, 2007.
Correspondence should be addressed to Prof. Cecilia Bucci, Dipartimento di Scienze e Tecnologie Biologiche ed Ambientali, Università del Salento, Via Provinciale Monteroni, 73100 Lecce, Italy. Email: cecilia.bucci{at}unile.it
This article has been cited by other articles:
M. Sumakovic, J. Hegermann, L. Luo, S. J. Husson, K. Schwarze, C. Olendrowitz, L. Schoofs, J. Richmond, and S. Eimer
UNC-108/RAB-2 and its effector RIC-19 are involved in dense core vesicle maturation in Caenorhabditis elegans
J. Cell Biol., September 21, 2009; 186(6): 897 - 914.
[Abstract] [Full Text] [PDF]
K. Romero Rosales, E. R. Peralta, G. G. Guenther, S. Y. Wong, and A. L. Edinger
Rab7 Activation by Growth Factor Withdrawal Contributes to the Induction of Apoptosis
Mol. Biol. Cell, June 15, 2009; 20(12): 2831 - 2840.
[Abstract] [Full Text] [PDF]
C. Cao, J. M. Backer, J. Laporte, E. J. Bedrick, and A. Wandinger-Ness
Sequential Actions of Myotubularin Lipid Phosphatases Regulate Endosomal PI(3)P and Growth Factor Receptor Trafficking
Mol. Biol. Cell, August 1, 2008; 19(8): 3334 - 3346.
[Abstract] [Full Text] [PDF]
|
|
|
|
 |
|